Infectious Disease Clinics of North America volume 23, issue 3, P535-556 2009 DOI: 10.1016/j.idc.2009.04.014 View full text
Peter K. Linden

Abstract: Despite significant advances in the prevention, diagnosis, and treatment of infection in the immunocompromised host, it remains a major cause of morbidity, increased length of stay, total costs, and of course mortality. Intensive care mortality rates are significantly higher among immunocompromised hosts in part due to the higher incidence of infection severity. The superimposition of the compromised host defenses and critical illness makes the detection and management of infections in such patients more diffi…

expand abstract